Further mechanistic exploration revealed that, compared to the NC group, the ACVR2A-inhibitor cohort exhibited a substantial increase in migratory and invasive cell populations, as well as colony formation, thereby affirming ACVR2A’s role in thwarting CRC evolution by curtailing cell proliferation, migration, and invasion. Here, ACVR2A is linked to colorectal carcinoma.